Dongjin Wang

2.3k total citations
38 papers, 852 citations indexed

About

Dongjin Wang is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Dongjin Wang has authored 38 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Dongjin Wang's work include Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (5 papers) and Advanced SAR Imaging Techniques (5 papers). Dongjin Wang is often cited by papers focused on Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (5 papers) and Advanced SAR Imaging Techniques (5 papers). Dongjin Wang collaborates with scholars based in China, United States and Norway. Dongjin Wang's co-authors include Yang Yang, Shouyin Di, Shuai Jiang, Tian Li, Zhiqiang Ma, Wei Hu, Zhi Yang, Wei Yi, Yue Li and Chongxi Fan and has published in prestigious journals such as PLoS ONE, Cellular and Molecular Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Dongjin Wang

35 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongjin Wang China 13 463 146 125 116 109 38 852
Qiuhuan Yuan China 20 470 1.0× 136 0.9× 141 1.1× 182 1.6× 133 1.2× 44 1.1k
Alessia Ferrarini Spain 15 504 1.1× 145 1.0× 124 1.0× 115 1.0× 70 0.6× 26 880
Chenxi Lu China 18 482 1.0× 134 0.9× 127 1.0× 114 1.0× 69 0.6× 66 1.1k
Ye Wu China 18 307 0.7× 73 0.5× 100 0.8× 132 1.1× 126 1.2× 50 853
Yimu Lai United States 15 427 0.9× 97 0.7× 106 0.8× 113 1.0× 197 1.8× 20 746
Meng Yuan China 21 503 1.1× 166 1.1× 101 0.8× 128 1.1× 260 2.4× 68 1.2k
Mingzhi Shen China 22 482 1.0× 108 0.7× 128 1.0× 220 1.9× 210 1.9× 45 1.2k

Countries citing papers authored by Dongjin Wang

Since Specialization
Citations

This map shows the geographic impact of Dongjin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongjin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongjin Wang more than expected).

Fields of papers citing papers by Dongjin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongjin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongjin Wang. The network helps show where Dongjin Wang may publish in the future.

Co-authorship network of co-authors of Dongjin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongjin Wang. A scholar is included among the top collaborators of Dongjin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongjin Wang. Dongjin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Can, Xiaolu Nie, Zhifen Chen, Jason Zhensheng Qu, & Dongjin Wang. (2025). Stenotic left atrioventricular valve after atrioventricular septal defect repair: A distinct surgical phenotype. Journal of Thoracic and Cardiovascular Surgery. 171(3). e66–e67.
2.
Xu, Can, et al.. (2025). Protective effects of Apelin-13 on nicotine-induced H9c2 cardiomyocyte apoptosis and oxidative stress. Tobacco Induced Diseases. 23(March). 1–10.
3.
Wang, Hui, Tong Ji, Ling Liu, et al.. (2025). Histone methyltransferase KMT2A promotes pulmonary fibrogenesis via targeting pro‐fibrotic factor PU.1 in fibroblasts. Clinical and Translational Medicine. 15(2). e70217–e70217. 2 indexed citations
4.
Qiao, Liang, Zeyi Zhou, Hui Li, et al.. (2023). Identification of pathological-related and diagnostic potential circular RNAs in Stanford type A aortic dissection. Frontiers in Cardiovascular Medicine. 9. 1074835–1074835. 5 indexed citations
5.
Li, Kunsheng, et al.. (2022). LncRNA KCNQ1OT1 Participates in Ox-LDL-Induced Proliferation/Apoptosis Imbalance in Vascular Smooth Muscle Cells by Regulating the MiR-196a-5p/FOXO1 Axis. Journal of Stroke and Cerebrovascular Diseases. 31(8). 106622–106622. 3 indexed citations
6.
Zhou, Zeyi, Yan Liu, Shijuan Gao, et al.. (2021). Excessive DNA damage mediates ECM degradation via the RBBP8/NOTCH1 pathway in sporadic aortic dissection. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(2). 166303–166303. 11 indexed citations
7.
Zhong, Kai, et al.. (2021). circ_TGFBR2 Inhibits Vascular Smooth Muscle Cells Phenotypic Switch and Suppresses Aortic Dissection Progression by Sponging miR-29a. Journal of Inflammation Research. Volume 14. 5877–5890. 12 indexed citations
8.
Li, Kunsheng, Yang Bai, Jie Li, et al.. (2021). LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway. International Journal of Cardiology. 342. 72–81. 39 indexed citations
9.
Zhu, Xiyu, et al.. (2020). Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases. Frontiers in Cardiovascular Medicine. 7. 597932–597932. 22 indexed citations
10.
Tang, Xinlong, Xiyu Zhu, Qing Zhou, et al.. (2019). Expression profiles of circRNAs and the potential diagnostic value of serum circMARK3 in human acute Stanford type A aortic dissection. PLoS ONE. 14(6). e0219013–e0219013. 25 indexed citations
11.
Li, Yue, Zhiqiang Ma, Shuai Jiang, et al.. (2017). A global perspective on FOXO1 in lipid metabolism and lipid-related diseases. Progress in Lipid Research. 66. 42–49. 128 indexed citations
12.
Jiang, Shuai, Jing Han, Tian Li, et al.. (2017). Curcumin as a potential protective compound against cardiac diseases. Pharmacological Research. 119. 373–383. 102 indexed citations
13.
Xin, Zhenlong, Zhiqiang Ma, Shuai Jiang, et al.. (2016). FOXOs in the impaired heart: New therapeutic targets for cardiac diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(2). 486–498. 62 indexed citations
14.
Li, Tian, Shuai Jiang, Zhi Yang, et al.. (2016). Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?. Cellular and Molecular Life Sciences. 74(8). 1413–1429. 51 indexed citations
15.
Li, Qingguo, Mingna Li, Zhong Wu, et al.. (2011). Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. International Journal of Cardiology. 166(3). 702–708. 23 indexed citations
16.
Xu, Wei, Dongxia Hou, Xiangrui Jiang, et al.. (2011). The protective role of peroxisome proliferator‐activated receptor γ coactivator‐1α in hyperthyroid cardiac hypertrophy. Journal of Cellular Physiology. 227(9). 3243–3253. 8 indexed citations
17.
Wang, Dongjin. (2010). Genetic Variation in CAPN3 Gene and Its Relationship with Carcass Traits in Cattle. Xumu shouyi xuebao. 1 indexed citations
18.
Yang, Chi, Li Shen, Zhengfeng Xu, et al.. (2009). A novel competitive fluorescent multiplex STR polymorphism assay for rapid, reliable and single‐tube screening of 22q11.2 copy‐number aberrations. Electrophoresis. 30(3). 465–471. 8 indexed citations
19.
Yi, Long, Zhengfeng Xu, Xuming Mo, et al.. (2006). New tetranucleotide STRP markers for detecting the 22q11.2 deletion. Molecular and Cellular Probes. 20(6). 359–365. 5 indexed citations
20.
Chen, Weidong, Shanjia Xu, Dongjin Wang, & Falin Liu. (2002). The real-time extraction technique of swept frequency nonlinearity of MM-wave LFMCW radar. 411–412.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiuhuan Yuan Breakdown of academic impact, for papers by Alessia Ferrarini Breakdown of academic impact, for papers by Chenxi Lu Breakdown of academic impact, for papers by Ye Wu Breakdown of academic impact, for papers by Yimu Lai Breakdown of academic impact, for papers by Meng Yuan Breakdown of academic impact, for papers by Mingzhi Shen
Rankless by CCL
2026